trilostane has been researched along with Pituitary Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cross, E; Moreland, R; Wallack, S | 1 |
| Nicholls, PK; Petrus, D; Skelly, BJ | 1 |
| Füessl, HS | 1 |
| Adams, EF; Ashby, MJ; Burrin, J; Drucker, R; Mashiter, K; Stringer, K; Yeo, TH | 1 |
1 review(s) available for trilostane and Pituitary Neoplasms
| Article | Year |
|---|---|
Feline pituitary-dependent hyperadrenocorticism and insulin resistance due to a plurihormonal adenoma.
Topics: Adrenocortical Hyperfunction; Animals; Antineoplastic Agents; Cat Diseases; Cats; Dihydrotestosterone; Fatal Outcome; Female; Insulin Resistance; Pituitary Gland; Pituitary Neoplasms | 2012 |
3 other study(ies) available for trilostane and Pituitary Neoplasms
| Article | Year |
|---|---|
Use of trilostane for the treatment of pituitary-dependent hyperadrenocorticism in a cat.
Topics: 3-Hydroxysteroid Dehydrogenases; Adrenocortical Hyperfunction; Animals; Candidiasis; Cat Diseases; Cats; Death, Sudden; Diagnosis, Differential; Dihydrotestosterone; Enzyme Inhibitors; Male; Pituitary Neoplasms; Renal Insufficiency | 2003 |
[Secondary forms of hypertension. 5. Hypertension caused by Cushing syndrome and Conn's disease].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Algorithms; Cushing Syndrome; Diagnosis, Differential; Dihydrotestosterone; Diuretics; Enzyme Inhibitors; Humans; Hyperaldosteronism; Hypertension; Magnetic Resonance Angiography; Mineralocorticoid Receptor Antagonists; Pituitary Neoplasms; Spironolactone; Tomography, X-Ray Computed | 2002 |
Effect of nivazol on ACTH secretion by human pituitary corticotrophic tumours in cell culture.
Topics: Adrenocorticotropic Hormone; Arginine Vasopressin; Cells, Cultured; Corticotropin-Releasing Hormone; Cushing Syndrome; Dihydrotestosterone; Humans; Pituitary Neoplasms; Pregnadienes | 1985 |